Evidence Hub

In vitro activity of gemifloxacin against Streptococcus pneumoniae isolates in Germany

Lemmen S, Al-Lahham A, Lütticken R, Reinert RR

Chemotherapy, 2001

Abstract

The MICs (minimal inhibitory concentrations) of gemifloxacin, moxifloxacin, ofloxacin, ciprofloxacin, levofloxacin, sparfloxacin, penicillin G, tetracycline and erythromycin were determined for 200 clinical pneumococcal isolates using the microbroth dilution method. MIC(50) and MIC(90) values were as follows (mg/l): 0.016 and 0.016 (gemifloxacin, penicillin-intermediate strains), 0.03 and 0.06 (gemifloxacin, penicillin-susceptible strains); 0.125-0.5 and 0.25 (moxifloxcacin); 1-2 and 4 (ciprofloxacin and ofloxacin); 1 and 2 (levofloxacin), and 0.25-0.5 and 0.5 (sparfloxacin). MIC(50) and MIC(90) values for the fluoroquinolones were nearly identical for individual antimicrobial agents in the penicillin-susceptible and penicillin-intermediate groups of strains. Erythromycin and tetracycline were less active against penicillin-intermediate pneumococci isolates (erythromycin: MIC(90) 8 mg/l; MIC range 0.06-> or =64 mg/l; tetracycline: MIC(90) > or =64 mg/l, MIC range 0.25- > or =64 mg/l) as compared to penicillin-susceptible isolates (erythromycin: MIC(90) 0.5 mg/l, MIC range 0.06-> or =64 mg/l; tetracycline: MIC(90) 8 mg/l, MIC range 0.06-> or =64 mg/l).

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free